SEC Company Response from Anixa Biosciences Inc (ANIX) (CIK 0000715446) (ANIX) — Oct 24, 2017
Anixa Biosciences Inc (ANIX) (CIK 0000715446)
Date: Oct. 24, 2017 · CIK: 0000715446 · Accession: 0001513162-17-000286
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220963
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Re: ITUS Corporation Registration Statement on Form S-3 File No. 333-220963
Dear Ms. Woo:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ITUS Corporation (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Standard Time on Thursday, October 26, 2017, or as soon as practicable thereafter.
Please note that we acknowledge the following:
·
should the Securities and Exchange Commission (the “Commission”) or the staff (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/ Dr. Amit Kumar
Show Raw Text
CORRESP 1 filename1.htm S-3 Acceleration Request ITUS CORPORATION 3150 Almaden Expressway, Suite 250 San Jose, CA 95118 October 24, 2017 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attn: Jan Woo Re: ITUS Corporation Registration Statement on Form S-3 File No. 333-220963 Dear Ms. Woo: Pursuant to Rule 461 under the Securities Act of 1933, as amended, ITUS Corporation (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Standard Time on Thursday, October 26, 2017, or as soon as practicable thereafter. Please note that we acknowledge the following: · should the Securities and Exchange Commission (the “Commission”) or the staff (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; · the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and · the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, /s/ Dr. Amit Kumar Name: Dr. Amit Kumar Title: President and Chief Executive Officer